Instituto de Salud Carlos III (ISCIII)
Supporter
The Instituto de Salud Carlos III (ISCIII) is the main public research entity funding, managing and carrying out biomedical research in Spain. It is also the body responsible for managing the Health Research and Development Strategy within the framework of the National Plan of R&D.
Membership discount for your BMC & SpringerOpen article processing charges (APCs)
As an affiliated author, a membership discount is available on your APC.
Please follow the submission guidelines to benefit from this membership discount.
Instituto de Salud Carlos III (ISCIII)'s Articles
Page 4 of 23
-
Citation: Orphanet Journal of Rare Diseases 2022 17:418
-
Neighborhood environmental factors linked to hospitalizations of older people for viral lower respiratory tract infections in Spain: a case-crossover study
Citation: Environmental Health 2022 21:107 -
Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes
Citation: Fluids and Barriers of the CNS 2022 19:88 -
Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study
Citation: Biology of Sex Differences 2022 13:64 -
Correction: Nut consumption is associated with a shift of the NMR lipoprotein subfraction profile to a less atherogenic pattern among older individuals at high CVD risk
Citation: Cardiovascular Diabetology 2022 21:219 -
The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19)
Citation: Cardiovascular Diabetology 2022 21:216 -
Nut consumption is associated with a shift of the NMR lipoprotein subfraction profile to a less atherogenic pattern among older individuals at high CVD risk
Citation: Cardiovascular Diabetology 2022 21:189 -
Predictors and changes of physical activity in idiopathic pulmonary fibrosis
Citation: BMC Pulmonary Medicine 2022 22:340 -
Clinical improvements after treatment with a low-valine and low-fat diet in a pediatric patient with enoyl-CoA hydratase, short chain 1 (ECHS1) deficiency
Citation: Orphanet Journal of Rare Diseases 2022 17:340 -
Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study
Citation: BMC Infectious Diseases 2022 22:721 -
Temporally ordered associations between type 2 diabetes and brain disorders – a Danish register-based cohort study
Citation: BMC Psychiatry 2022 22:573 -
Association between histological diaphragm atrophy and ultrasound diaphragm expiratory thickness in ventilated patients
Citation: Journal of Intensive Care 2022 10:40 -
Neurohormetic phytochemicals in the pathogenesis of neurodegenerative diseases
Citation: Immunity & Ageing 2022 19:36 -
HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection
Citation: BMC Genomics 2022 23:455 -
An epigenome-wide study of DNA methylation profiles and lung function among American Indians in the Strong Heart Study
Citation: Clinical Epigenetics 2022 14:75 -
The InfAct proposal for a sustainable European health information infrastructure on population health: the Distributed Infrastructure on Population Health (DIPoH)
Citation: Archives of Public Health 2022 80:139 -
Correction: Effect of the Lights4Violence intervention on the sexism of adolescents in European countries
Citation: BMC Public Health 2022 22:945 -
Usefulness of a commercial LAMP assay for detection of malaria infection, including Plasmodium knowlesi cases, in returning travelers in Spain
Citation: BMC Research Notes 2022 15:147 -
Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004–2018
Citation: BMC Infectious Diseases 2022 22:379 -
Tracking and risk of abdominal and general obesity in children between 4 and 9 years of age. The Longitudinal Childhood Obesity Study (ELOIN)
Citation: BMC Pediatrics 2022 22:198